Log In
Print
BCIQ
Print
Print this Print this
 

ZPL-5212372 (formerly PF-5212372, PLA-950)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionTopical phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) inhibitor
Molecular Target Phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) (cPLA2-alpha)
Mechanism of ActionPhospholipase A2 inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

Partner

Ziarco Pharma Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today